Who are Venlafaxine IR and Venlafaxine XR's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Pristiq, Effexor, Dulox capsule (60mg), Aripiprazole + desvenlafaxine succinate sustained release, Higher-dose venlafaxine, Treatment (Viibryd).

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/venlafaxine-ir-and-venlafaxine-xr.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-17 · How we verify

Venlafaxine IR and Venlafaxine XR — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Venlafaxine IR and Venlafaxine XR (Venlafaxine IR and Venlafaxine XR) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Serotonin-norepinephrine reuptake inhibitor (SNRI). Area: Psychiatry / Mental Health.

marketed Serotonin-norepinephrine reuptake inhibitor (SNRI) Serotonin transporter (SERT) and norepinephrine transporter (NET) Psychiatry / Mental Health Small molecule Live · refreshed every 30 min

Target snapshot

Venlafaxine IR and Venlafaxine XR (Venlafaxine IR and Venlafaxine XR) — North Dakota State University. Venlafaxine inhibits the reuptake of serotonin and norepinephrine in the central nervous system, increasing their availability at synaptic sites.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Venlafaxine IR and Venlafaxine XR TARGET	Venlafaxine IR and Venlafaxine XR	North Dakota State University	marketed	Serotonin-norepinephrine reuptake inhibitor (SNRI)	Serotonin transporter (SERT) and norepinephrine transporter (NET)
Pristiq	Desvenlafaxine Succinate	Pfizer	marketed	Serotonin-norepinephrine reuptake inhibitor (SNRI)	Serotonin and norepinephrine reuptake	2008-01-01
Effexor	Venlafaxine Hydrochloride	Pfizer	marketed	Serotonin-Norepinephrine Reuptake Inhibitor (SNRI)	Serotonin and norepinephrine reuptake transporters	1993-01-01
Dulox capsule (60mg)	Dulox capsule (60mg)	Ain Shams University	marketed	Serotonin-norepinephrine reuptake inhibitor (SNRI)	Serotonin transporter (SERT) and norepinephrine transporter (NET)
Aripiprazole + desvenlafaxine succinate sustained release	Aripiprazole + desvenlafaxine succinate sustained release	Pfizer	marketed	Atypical antipsychotic + serotonin-norepinephrine reuptake inhibitor (SNRI) combination	Dopamine D2/D3 receptors (aripiprazole); serotonin transporter (SERT) and norepinephrine transporter (NET) (desvenlafaxine)
Higher-dose venlafaxine	Higher-dose venlafaxine	University of Pittsburgh	marketed	Serotonin-norepinephrine reuptake inhibitor (SNRI)	Serotonin transporter (SERT), norepinephrine transporter (NET)
Treatment (Viibryd)	Treatment (Viibryd)	Southern California Institute for Research and Education	marketed	Serotonin-norepinephrine reuptake inhibitor (SNRI) with 5-HT1A partial agonist activity	Serotonin transporter (SERT); 5-HT1A receptor (partial agonist)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Serotonin-norepinephrine reuptake inhibitor (SNRI) class)

Pfizer · 3 drugs in this class
Wyeth is now a wholly owned subsidiary of Pfizer · 3 drugs in this class
National Institute of Mental Health (NIMH) · 2 drugs in this class
Zhejiang Huahai Pharmaceutical Co., Ltd. · 2 drugs in this class
Eli Lilly and Company · 2 drugs in this class
New York State Psychiatric Institute · 1 drug in this class
North Dakota State University · 1 drug in this class
Ministry of Health & Welfare, Korea · 1 drug in this class
Purdue Pharma, Canada · 1 drug in this class
Shanghai Mental Health Center · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Venlafaxine IR and Venlafaxine XR — Competitive Intelligence Brief. https://druglandscape.com/ci/venlafaxine-ir-and-venlafaxine-xr. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab